More on MYCO
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.02 |
|
|||
| Open | $0.02 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.02 | ||||
| Day Low | $0.02 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 0 | ||||
- Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
- Mydecine Innovations Group Announces Director Resignation
- Mydecine Announces Update Regarding the Special Access Program
- Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
- Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
- Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
- Mydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing
- Mydecine Innovations Announces Closing of Prospectus Supplement Financing
- Mydecine Innovations Group Files Prospectus Supplement
- Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2023
Entities mentioned with MYCO
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Canaccord Genuity | View Related Stories »
- Chrysler LLC | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Hedge Funds | View Related Stories »
- Show More...
